 Shares of Outlook Therapeutics NASDAQ:OTLK moved higher by 2.8 in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 133.33 year over year to 0.07, which were in line with the estimate of 0.07. 